{"id":"W2599463965","doi":"10.1200/jco.2012.30.15_suppl.tps2615","title":"A phase I study of BMS-936558 in combination with gemcitabine/cisplatin, pemetrexed/cisplatin, or carboplatin/paclitaxel in patients with treatment-naive, stage IIIB/IV non-small-cell lung cancer.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Pemetrexed; Medicine; Carboplatin; Gemcitabine; Lung cancer; Tolerability; Internal medicine; Oncology; Cisplatin; Bevacizumab; Chemotherapy; Paclitaxel; non-small cell lung cancer (NSCLC); Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00127796,0.002134791,0.002760064,0.0007281146,0.0005685615,0.00119706,0.001376173,0.001589396,0.005381742],"category_scores_gemma":[0.0007954566,0.0009446947,0.001821676,0.0006294061,0.001216454,0.001147579,0.0004227913,0.004061854,0.001749425],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001054859,"about_ca_system_score_gemma":0.002300273,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001543538,"about_ca_topic_score_gemma":0.00384382,"domain_scores_codex":[0.9996482,0.0001364136,0.00001918799,0.00007436224,0.00003753395,0.00008425461],"domain_scores_gemma":[0.9992736,0.00006403943,0.0001181818,0.00004872021,0.00004141121,0.0004539934],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6262718,0.2034789,0.006012211,0.001400236,0.001793785,0.0005087978,0.0004851965,0.003153077,0.06150534,0.0004191721,0.006779689,0.08819179],"study_design_scores_gemma":[0.4213202,0.5657066,0.007086082,0.00003010393,0.0003736833,0.0002017246,0.00005775323,0.0007274904,0.002203847,0.0001670522,0.002095129,0.00003033038],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9871507,0.001977524,0.000550666,0.0006079405,0.0002578071,0.005760856,0.001477615,0.0001650423,0.002051821],"genre_scores_gemma":[0.9773956,0.003437636,0.002587743,0.001638889,0.0003175834,0.00638347,0.003394704,0.0000589647,0.004785369],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005381742,"threshold_uncertainty_score":0.0180037,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04032783369128001,"score_gpt":0.3947619390814295,"score_spread":0.3544341053901495,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}